The Effect of Cyclosporin and Lipopolysaccharide on Fibroblasts: Implications for Cyclosporin‐Induced Gingival Overgrowth
- 1 May 1992
- journal article
- research article
- Published by Wiley in The Journal of Periodontology
- Vol. 63 (5) , 397-404
- https://doi.org/10.1902/jop.1992.63.5.397
Abstract
Drug‐induced gingival overgrowth is an adverse side effect associated principally with 3 different types of drugs; specifically the antiepileptic phenytoin, the calcium channel antagonist nifedipine, and the immunosuppressant cyclosporin. The present study has analyzed the effect of cyclosporin and lipopolysaccharide on fibroblasts from 3 different sources: 1) normal healthy human gingiva (NHGF); 2) overgrown gingiva from 2 patients taking cyclosporin (CHGF); and 3) human fetal lung (WI‐38). Fibroblasts isolated from cyclosporin‐associated gingival overgrowth were significantly less responsive to cyclosporin in terms of DNA, total protein, and proteoglycan synthesis. This finding supports the in vivo response where few fibroblasts are seen but marked overgrowth of fibrous tissue occurs. Lipopolysaccharide derived from Fusobacterium nucleatum and Escherichia coli was capable of inhibiting DNA synthesis significantly in all 3 fibroblast types. Total protein synthesis by CHGF cells was inhibited differentially by Fusobacterium nucleatum LPS and addition of cyclosporin to this system resulted in reversal of the inhibition. A synergistic effect was noted when the proteoglycan output of NHGF cells was assessed in response to co‐incubation with cyclosporin and Escherichia coli LPS. The study shows that bacterial LPS may be an important co‐factor in the pathogenesis of cyclosporin‐induced gingival overgrowth. J Periodontol 1992; 63:397– 404.Keywords
This publication has 23 references indexed in Scilit:
- Cyclosporin A: recent developments in the mechanism of action and clinical applicationCurrent Opinion in Immunology, 1990
- Cyclosporine-induced gingival overgrowth: An ultrastructural stereologic studyOral Surgery, Oral Medicine, Oral Pathology, 1988
- Clonal heterogeneity in fibroblast phenotype: Implications for the control of epithelial‐mesenchymal interactionsBioEssays, 1987
- Cyclosporine and gingival overgrowthJournal of Oral Pathology & Medicine, 1987
- Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and salivaOral Surgery, Oral Medicine, Oral Pathology, 1987
- Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasiaOral Surgery, Oral Medicine, Oral Pathology, 1986
- Gingival hyperplasia associated with cyclosporin A. A report of two casesBritish Dental Journal, 1984
- Gingival hyperplasia associated with nifedipine therapy: Report of a caseOral Surgery, Oral Medicine, Oral Pathology, 1984
- Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapyOral Surgery, Oral Medicine, Oral Pathology, 1983
- DISTRIBUTION AND PERSISTENCE OF CYCLOSPORIN IN HUMAN TISSUESThe Lancet, 1982